D van Zwoll

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Therapeutic agents which may be able to enhance the antioxidant screen of the epithelial surface of the lung have the potential to influence the progression of lung inflammation. This study evaluates(More)
beta(2)-Agonists are known to have anti-inflammatory efficacy. In this context, beta(2)-agonists are also capable of inhibiting oxidant production of cultured inflammatory cells. As the mechanisms of(More)
  • 1